| Jeanna O'neill, | |
|
574 County Road 1121, Arlington, KY 42021-8544 | |
| (618) 944-3354 | |
| Not Available |
| Full Name | Jeanna O'neill |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 574 County Road 1121, Arlington, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558061952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 1065649 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeanna O'neill, 574 County Road 1121, Arlington, KY 42021-8544 Ph: (618) 944-3354 | Jeanna O'neill, 574 County Road 1121, Arlington, KY 42021-8544 Ph: (618) 944-3354 |
News Archive
A new Mayo Clinic study provides strong evidence that the joint effects of common DNA variations in several genes that encode proteins within a well-defined biological pathway largely explain why some persons get Parkinson's disease while others don't, and even predict with great accuracy at what age people might develop their first symptoms.
In a new study presented at the Alzheimer's Association's annual International Conference in Paris it was reported that older people whose brain scans showed signs of amyloid plaques - an early indicator of Alzheimer's disease - but who were otherwise healthy, had twice the risk of falls as people without brain amyloid.
The Hill: "Democrats on the Senate Finance Committee are trying to make the case that the healthcare bill will strengthen Medicare and Medicaid by finding major savings through a crack down on fraud, waste and abuse."
Inhibitex, Inc. today reported the completion of its previously announced $23 million private placement of common stock and warrants. Investors in the private placement purchased units, each consisting of one share of common stock and a warrant to purchase .45 of a share of common stock, at a purchase price of $1.28 per unit, which is equal to the consolidated closing bid price of the common stock as reported on the NASDAQ Capital Market for October 22, 2009, plus $0.06.
› Verified 3 days ago